a) Micro-computed tomography (micro-CT) quantification of total
tumor volume (mm3) of tumors from sgKeap1.4 (n
= 5) or sgTom (n = 3) infected animals at 4 and
5 months post infection. b) Combined quantification of tumor burden
(total tumor area/total lung area) in KrasLSL-G12D/+;
p53fl/fl (KP) animals after infection with pSECC
lentiviruses. Left panel: tumor burden 21 weeks post infection of animals
infected with control sgTom (n = 3) or sgKeap1.2
(n = 7). Right panel: tumor burden 21 weeks post
infection of animals infected with control sgTom (n =
6) or sgKeap1.4 (n = 5). The asterisks indicate
statistical significance obtained from comparing KP-sgKeap1 samples to KP-sgTom
samples. c) Distribution of histological tumor grades in KP animals
21 weeks after infection with pSECC lentiviruses expressing: control (sgTom, KP;
n = 7 mice), sgKeap1.2 (KP; n
= 3 mice). d) Quantification of phospho-Histone H3 (pHH3)
positive nuclei per mm2 to assess the mitotic index of tumor cells
from lung tumors in KP animals 21 weeks after infection with pSECC lentiviruses
expressing: control (sgTom, n = 14 tumors), or
sgKeap1.2 (n = 50 tumors). e) Contingency
tables demonstrating correlation between nuclear Nrf2 expression and Nqo1
expression. Top panel: quantified tumors obtained from control sgTom infected
mice. Bottom panel: quantified tumors obtained from sgKeap1.2 infected mice
(two-sided Fisher's exact test,
****p < 0.0001).
f) Representative hematoxylin and eosin (H&E) and
immunohistochemistry (IHC) staining of serial sections from lung tumors of mice
21 weeks after infection with pSECC-sgTom (top panel) or pSECC-sgKeap1.2 (bottom
panel). First panels: representative overall lung tumor burden. Second panel:
higher magnification H&E of representative tumors. Third panel: Nuclear
Nrf2 IHC. Fourth panel: Nqo1 IHC. Note the accumulation of Nrf2 and Nqo1 occurs
only in tumors from pSECC-sgKeap1.2 mice. Inset represents higher magnification.
Scale bars are 100um. g) Oxidative stress index as judged by
% 8-oxo-dG positive nuclei (n = 10 per
genotype). All error bars denote s.e.m. Obtained from two-sided
Student's t-test unless otherwise noted.
*p < 0.05,
***p < 0.001,
****p < 0.0001.
h)
KEAP1/NRF2-mutant versus WT human LUAD biopsy IHC for NQO1. All
tumor samples were confirmed to be KEAP1/NRF2 mutant via
targeted exome sequencing (See Supplementary Table 1). Right legend depicts examples of staining
criteria.